Viking Global Investors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Viking Global Investors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,642,700	Closed	-$413M	–	100
2023 Q4	$413M	Hold	6,642,700	–	–	1.51%	25
2023 Q3	$147M	Buy	+6,642,700	New	+$139M	0.6%	43

Viking Global Investors's RYZB Position: Q1 2024 in Review

Viking Global Investors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 6,642,700 shares — an estimated $413M sold.

Viking Global Investors first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $413M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Viking Global Investors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Viking Global Investors sold 6,642,700 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $413M.
Viking Global Investors first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Viking Global Investors's RayzeBio, Inc. Common Stock position peaked at $413M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Viking Global Investors's 13F filing for Q1 2024, filed 15 May 2024.